A 750

Pill imprint A 750 has been identified as Salsalate 750 MG.

Salsalate is used in the treatment of osteoarthritis; rheumatoid arthritis and belongs to the drug class salicylates. Risk cannot be ruled out during pregnancy.

Salsalate 750 MG is not subject to the Controlled Substances Act.
See also related documents.

Salsalate Images

Salsalate

Imprint:: A 750
Strength:: 750 MG
Color:: Yellow
Shape:: Elliptical / Oval
Availability:: Prescription only
Drug Class:: Salicylates
Pregnancy Category:: C - Risk cannot be ruled out
CSA Schedule:: N - Not a controlled drug
Manufacturer:: Rugby

View Drug Details Print Page

More SALSALATE resources

Salsalate (Wolters Kluwer)
salsalate (Cerner Multum)
Salsalate (AHFS DI)
Salsalate (FDA)

SALSALATE is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Sign In or Register

Forgot password?

Related Salsalate Information

Availability Prescription only

CSA Schedule Not a controlled drug

Pregnancy Category Risk cannot be ruled out

Reviews

Average User Rating

1 User Review

7.0

Rate it!

Related Pages

Drug Class

Salicylates

Recently Approved

Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...

More...

FDA Consumer Updates

More FDA Updates...

Related News and Articles

Ampio Pharmaceuticals, Inc. Announces Statistically Significant Improvement in Pain Relief for its Lead Product, Ampion(TM) in the Osteoarthritis of the Knee Trial. 31 January 2012
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new...
Too Many Rheumatoid Arthritis Patients Inactive, Study Finds 26 January 2012
More than 40 percent of rheumatoid arthritis patients live a sedentary life, a new study finds. It used to be thought that medication and rest was the best...
More Known About Proteins That Cause Autoimmune Diseases 17 January 2012
A new study says more than 32 million people in the United States have autoantibodies, which are proteins produced in the immune system that attack the body's...
Knee Arthritis May Speed Up Process Linked to Cell Aging 17 January 2012
A process linked to natural cell aging has now also been associated with knee osteoarthritis, researchers say. Telomeres -- lengths of DNA on the ends of...
Herbal Medicines for Arthritis Not Backed by Evidence 11 January 2012
There is little evidence to support the widespread use of herbal medicines to relieve the symptoms of osteoarthritis, according to a review of these...

Get Updates by Email

Email me about salsalate systemic:

Did you find this page helpful? Yes No

Support

About Drugs.com

Your Privacy

Follow us on: Google+ Facebook Twitter

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy